Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.72% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5201
Black Diamond Therapeutics
BDTX
$116M
| $387K | ﹤0.01% |
229,189
-307,031
| -57% | -$947K |
|
5202
Direxion Daily Real Estate Bear 3X ETF
DRV
$25.3M
| $387K | ﹤0.01% |
5,746
-3,233
| -36% | -$150K |
|
5203
Innovator US Equity Power Buffer ETF January
PJAN
$1.43B
| $386K | ﹤0.01% |
13,132
+1,432
| +12% | +$44.4K |
|
5204
Ceragon Networks
CRNT
$200M
| $385K | ﹤0.01% |
210,391
-86,355
| -29% | -$205K |
|
5205
Hingham Institution for Saving
HIFS
$680M
| $385K | ﹤0.01% |
1,528
-168
| -10% | -$49.1K |
|
|
FREE
5206
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $385K | ﹤0.01% |
100,379
-166,631
| -62% | -$908K |
|
5207
Viant Technology
DSP
$275M
| $384K | ﹤0.01% |
91,249
-14,679
| -14% | -$71.9K |
|
|
BFX
5208
DELISTED
BowFlex Inc.
BFX
| $384K | ﹤0.01% |
235,890
-129,861
| -36% | -$261K |
|
5209
Mistras Group
MG
$576M
| $383K | ﹤0.01% |
85,893
-80,765
| -48% | -$457K |
|
|
AMNB
5210
DELISTED
American National Bankshares Inc
AMNB
| $383K | ﹤0.01% |
11,986
-15,365
| -56% | -$526K |
|
5211
Citizens
CIA
$201M
| $382K | ﹤0.01% |
114,669
-133,731
| -54% | -$508K |
|
5212
Air T
AIRT
$79.2M
| $381K | ﹤0.01% |
22,250
+600
| +3% | +$9.96K |
|
5213
First Trust United Kingdom AlphaDEX Fund
FKU
$39.7M
| $381K | ﹤0.01% |
14,216
-122,329
| -90% | -$3.77M |
|
5214
MarketWise
MKTW
$54.2M
| $381K | ﹤0.01% |
8,385
+4,003
| +91% | +$236K |
|
5215
OP Bancorp
OPBK
$233M
| $381K | ﹤0.01% |
34,232
-59,057
| -63% | -$678K |
|
5216
Root
ROOT
$797M
| $381K | ﹤0.01% |
48,406
+32,044
| +196% | +$502K |
|
5217
Hydrofarm Holdings
HYFM
$7M
| $380K | ﹤0.01% |
19,611
-6,994
| -26% | -$225K |
|
5218
ARK Israel Innovative Technology ETF
IZRL
$141M
| $379K | ﹤0.01% |
21,994
-246
| -1% | -$4.74K |
|
5219
Neurogene
NGNE
$723M
| $379K | ﹤0.01% |
29,623
-1,522
| -5% | -$31.1K |
|
|
PCF
5220
High Income Securities Fund
PCF
$102M
| $378K | ﹤0.01% |
54,793
+17,954
| +49% | +$133K |
|
|
FEO
5221
DELISTED
First Trust/abrdn Emerging Opportunity Fund
FEO
| $378K | ﹤0.01% |
42,357
-132,302
| -76% | -$1.16M |
|
|
USX
5222
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $377K | ﹤0.01% |
153,216
+28,671
| +23% | +$81.3K |
|
|
NSLR
5223
Neostellar Capital Corp
NSLR
$278M
| $376K | ﹤0.01% |
97,489
-339,221
| -78% | -$2.07M |
|
5224
UroGen Pharma
URGN
$2.35B
| $376K | ﹤0.01% |
45,010
-38,266
| -46% | -$317K |
|
5225
Evolv Technologies
EVLV
$1.05B
| $375K | ﹤0.01% |
176,784
+111,349
| +170% | +$290K |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.